IP Library Granted Patent US 11,224,362
Granted Patent B2
US 11,224,362 · App. 16/559,416 · Granted Jan 18, 2022

Method and/or system for determining blood glucose reference sample times

Inventors: Rebecca K. Gottlieb (Culver City, CA); Meena Ramachandran (San Francisco, CA)
Assignee: MEDTRONIC MINIMED, INC.
A61B5/14532A61B5/14503A61B5/4839A61B5/6849A61B5/7221A61B5/742A61M5/14244A61M5/1723A61M2005/14208A61M2205/18A61M2205/50A61M2230/201
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,224,362
App. No.
16/559,416
Granted
Jan 18, 2022
Kind
B2
Abstract

Subject matter disclosed herein relates to monitoring and/or controlling blood glucose levels in patients. In particular, times for obtaining metered blood glucose samples of a patient may be altered based, at least in part, on a blood glucose level of said patient observed from a blood glucose sensor.

Claims (29)

1. A method comprising:

obtaining from a patient a first blood glucose reference sample measurement while monitoring a blood glucose level in the patient based on signals from a continuous blood glucose sensor;

determining an extension of a scheduled time for obtaining from the patient a second blood glucose reference sample measurement,

wherein the determining of the extension is performed by one or more processors and is based, at least in part, on a reliability indicator (RI) exceeding a first threshold, wherein the RI comprises a numerical value expressing an indication of a reliability of the continuous blood glucose sensor; and

responsive, at least in part, to the determined extension, generating signals to provide a message to an operator or attendant indicating an option to extend the scheduled time for obtaining the second blood glucose reference sample measurement.

2. The method of claim 1 , wherein the RI is based, at least in part, on observed trends in the signals from the continuous blood glucose sensor.

3. The method of claim 2 , wherein the observed trends comprise a reduced sensitivity of the continuous blood glucose sensor.

4. The method of claim 2 , wherein the observed trends comprise observed non-physiological anomalies or sensor drift.

5. The method of claim 1 , wherein the determining of the extension is further based, at least in part, on an observed blood glucose level being in a target range blood glucose level, and wherein the observed blood glucose level is based, at least in part, on the signals from the continuous blood glucose sensor.

6. The method of claim 1 , wherein the determining of the extension is further based, at least in part, on an observed blood glucose level being in a target range blood glucose level for more than a threshold duration, and wherein the observed blood glucose level is based, at least in part, on the signals from the continuous blood glucose sensor.

7. The method of claim 6 , wherein the RI is based, at least in part, on observed trends in the signals from the continuous blood glucose sensor.

8. The method of claim 7 , wherein the observed trends comprise a reduced sensitivity of the continuous blood glucose sensor.

9. The method of claim 7 , wherein the observed trends comprise observed non-physiological anomalies or sensor drift, or a combination thereof.

10. The method of claim 1 , wherein the generating of the signals to provide the message comprises displaying the message to the operator or attendant indicating the option to extend the scheduled time for obtaining the second blood glucose reference sample measurement.

11. An apparatus comprising:

a controller to:

receive signals associated with a value of a first blood glucose reference sample measurement taken from a patient;

monitor a blood glucose level in the patient based, at least in part, on signals from a continuous blood glucose sensor;

determine an extension of a scheduled time to obtain from the patient a second blood glucose reference sample measurement based, at least in part, on a reliability indicator (RI) exceeding a first threshold, wherein the RI comprises a numerical value to express an indication of a reliability of the continuous blood glucose sensor; and

responsive, at least in part, to the determined extension, generate signals to provide a message to an operator or attendant to indicate an option to extend the scheduled time to obtain the second blood glucose reference sample measurement.

12. The apparatus of claim 11 , wherein the RI is based, at least in part, on observed trends in the signals from the continuous blood glucose sensor.

13. The apparatus of claim 12 , wherein the observed trends comprise a reduced sensitivity of the continuous blood glucose sensor.

14. The apparatus of claim 12 , wherein the observed trends comprise observed non-physiological anomalies or sensor drift.

15. The apparatus of claim 11 , wherein to determine the extension further comprises to determine the extension based, at least in part, on an observed blood glucose level being within a target range blood glucose level, and wherein the observed blood glucose level is based, at least in part, on the signals from the continuous blood glucose sensor.

16. The apparatus of claim 11 , wherein to determine the extension further comprises to determine the extension based, at least in part, on an observed blood glucose level being within a target range blood glucose level for more than a threshold duration, and wherein the observed blood glucose level is based, at least in part, on the signals from the continuous blood glucose sensor.

17. The apparatus of claim 16 , wherein the RI is based, at least in part, on observed trends in the signals from the continuous blood glucose sensor.

18. The apparatus of claim 17 , wherein the observed trends comprise a reduced sensitivity of the continuous blood glucose sensor.

19. The apparatus of claim 17 , wherein the observed trends comprise observed non-physiological anomalies or sensor drift, or a combination thereof.

20. The apparatus of claim 11 , wherein to generate the signals to provide the message further comprises to display the message to the operator or attendant to indicate the option to extend the scheduled time to obtain the second blood glucose reference sample measurement.

Assignments (2)
SECURITY INTEREST Recorded Jan 16, 2026
From: MEDTRONIC MINIMED, INC.; COMPANION MEDICAL, INC.
To: CITIBANK, N.A.
Reel/Frame 074394/0237 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 3, 2019
From: GOTTLIEB, REBECCA K.; RAMACHANDRAN, MEENA
To: MEDTRONIC MINIMED, INC.
Reel/Frame 050252/0990 →
Cited By (1)
US 12,635,916